Abstract Transfer of a biosynthetic pathway between evolutionary distant organisms can create a metabolic shunt capable of bypassing the native regulation of the host organism, hereby improving the production of secondary metabolite precursor molecules for important natural products. Here, we report the engineering of Escherichia coli genes encoding the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway into the genome of Saccharomyces cerevisiae and the characterization of intermediate metabolites synthesized by the MEP pathway in yeast. Our UPLC-MS analysis of the MEP pathway metabolites from engineered yeast showed that the pathway is active until the synthesis of 2-C-methyl-D-erythritol-2,4-cyclodiphosphate, but appears to lack functionality of the last two steps of the MEP pathway, catalyzed by the [4Fe-4S] iron sulfur cluster proteins encoded by ispG and ispH. In order to functionalize the last two steps of the MEP pathway, we co-expressed the genes for the E. coli iron sulfur cluster (ISC) assembly machinery. By deleting ERG13, thereby incapacitating the mevalonate pathway, in conjunction with labeling experiments with U-13 C 6 glucose and growth experiments, we found that the ISC assembly machinery was unable to functionalize ispG and ispH. However, we have found that leuC and leuD, encoding the heterodimeric iron-sulfur cluster protein, isopropylmalate isomerase, can complement the S. cerevisiae leu1 auxotrophy. To our knowledge, this is the first time a bacterial iron-sulfur cluster protein has been functionally expressed in the cytosol of S. cerevisiae under aerobic conditions and shows that S. cerevisiae has the capability to functionally express at least some bacterial iron-sulfur cluster proteins in its cytosol.
Introduction
Isoprenoids, comprising more than 55,000 compounds, hold great potential as pharmaceuticals, flavors, fragrances, and, in general, high-value chemicals (Breitmaier 2006; McGarvey and Croteau 1995) . The complexity of these compounds and their relative scarcity in nature, however, render their production uneconomical and difficult via chemical synthesis or extraction. Here, metabolic engineering is an enabling technology for engineering heterologous biosynthesis in microorganisms toward developing scalable production methods (Ajikumar et al. 2008; Pirie et al. 2013; Yadav et al. 2012 ). Such engineering is not straightforward and requires optimization to establish an efficient biosynthetic pathway for synthesizing the product of interest, avoiding by-product formation and improving precursor supply (Keasling 2010) . Developments in metabolic engineering over the past two decades have significantly improved our ability to design, construct, and optimize biosynthetic pathways in microorganisms (Keasling 2012; Stephanopoulos 2012) . Isoprenoid biosynthesis has been engineered in both prokaryotic, Escherichia coli, and eukaryotic yeast cells for heterologous production of complex terpeneoid molecules (Ajikumar et al. 2010; Alper et al. 2005; Kroll et al. 2009; Martin et al. 2003; Ro et al. 2006; Wang et al. 2010) .
Isoprenoids are biosynthesized from isopentenyl diphosphate (IPP) produced in yeast by the mevalonate (MVA) pathway, starting with acetyl-CoA, and in E. coli by the 2-Cmethyl-D-erythritol-4-phosphate (MEP) pathway, starting with pyruvate and glyceraldehyde-3-phosphate (G3P; Fig. 1 ; Ajikumar et al. 2008) . The MEP pathway has been found to be stoichiometrically superior and less by-productaccumulating compared to the MVA pathway (Dugar and Stephanopoulos 2011) . Recently, the E. coli MEP pathway was engineered for high-level production of terpenoids and the bottleneck inhibitory steps identified (Ajikumar et al. 2010) . In another research, Maury et al. (2008) amplified the seven MEP pathway genes from E. coli genomic DNA and expressed them in Saccharomyces cerevisiae using a dualgalactose-inducible promoter system based on the GAL1 promoter and the GAL10 promoter. To test the activity of the MEP pathway in S. cerevisiae, the native MVA pathway which supplies precursors for ergosterol and other essential compounds was inhibited with the hypocholesterolemic drug lovastatin, which specifically inhibits the HMG-CoA reductase (Alberts et al. 1980 ) and prevents the growth of wild-type yeast (Maury et al. 2008) . Although Maury et al. (2008) reported that the MEP pathway expressing yeast showed some growth in the presence of lovastatin, significantly lower levels of terpenoids were produced by this strain compared to other native and non-native isoprenoid pathway-engineered cells (Ajikumar et al. 2010; Martin et al. 2003; Ro et al. 2006) .
In the present study, we sought to engineer the MEP pathway into S. cerevisiae and characterize metabolites in the pathway to identify bottlenecks. In order to create a stable strain amenable for further genetic modification, we chose to chromosomally integrate the seven MEP pathway genes from E. coli (Table 1 ) with the addition of the Idi gene, which encodes the E. coli IPP/dimethylallyl diphosphate (DMAPP) isomerase. These eight genes where synthesized and codon-optimized to improve their expression in S. cerevisiae. To test whether the chromosomally integrated pathway were functional in S. cerevisiae, we deleted the ERG13 gene, which encodes the HMG-CoA synthase of the MVA pathway. In contrast to the previous report (Maury et al. 2008) , the E. coli MEP pathway chromosomally Fig. 1 Overview of isoprenoid biosynthetic pathways. Green gene names are mevalonate pathway genes and red gene names are 2-Cmethyl-D-erythritol-4-phosphate (MEP) pathway genes. Gene/protein: ERG10/acetoacetyl-CoA thiolase, ERG13/3-hydroxy-3-methyl-glutarylCoA synthase, HMG1 and HMG2/3-hydroxy-3-methyl-glutaryl-CoA reductase, ERG12/mevalonate kinase, ERG8/phosphomevalonate kinase, ERG19/mevalonate-5-diphosphate decarboxylase, IDI and idi/isopentenyl diphosphate isomerase, ERG20/farnesyl diphosphate synthase, dxs/1-deoxy-D-xylulose-5-phosphate synthase, dxr/1-deoxy-D-xylulose-5-phosphate reductase, ispD/4-diphosphocytidyl-2-C-methyl-D-erythritol synthase, ispE/4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, ispF/ 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase, ispG/1-hydroxy-2-methyl-2-(E)-butenyl-4-phosphate synthase, ispH/1-hydroxy-2-methyl-2-(E)-butenyl-4-phosphate reductase. Pathway intermediates: FBP fructose bisphosphate, DHAP dihydroxyacetone phosphate, G3P glyceraldehyde 3-phosphate, PEP phosphoenolpyruvate, PYR pyruvate, ACCoA acetyl-CoA, AcACCoA acetoacetyl-CoA, HMG-CoA 3-hydroxy-3-methyl-glutaryl-CoA, MEV mevalonate, MEV-P mevalonate-5-phosphate, MEV-PP mevalonate diphosphate, IPP isopentenyl diphosphate, DMAPP dimethylallyl diphosphate, FPP farnesyl diphosphate, DXP 1-deoxy-D-xylulose-5-phosphate, MEP 2-C-methyl-D-erythritol-4-phosphate, CDP-ME 4-diphosphocytidyl-2-C-methyl-D-erythritol, CDP-MEP 2-phospho-4-diphosphocytidyl-2-C-methyl-D-erythritol, MEC 2-C-methyl-D-erythritol-2,4-cyclodiphosphate, HMBP 1-hydroxy-2-methyl-2-(E)-butenyl-4-phosphate expressed in S. cerevisiae was unable to support growth in the absence of IPP supplied by the MVA pathway. By analyzing the strain for MEP pathway metabolites using liquid chromatography-mass spectrometry, we identified both DXP and 2-C-methyl-D-erythritol-2,4-cyclodiphosphate (MEC). The results indicate that the MEP pathway is active up to MEC and that the problem thus originates from insufficient active expression of one or both of the two genes (ispG and ispH) downstream of MEC. We thereafter searched the literature to elucidate whether S. cerevisiae meets the cofactor requirements for the entire MEP pathway (Table 2) . From Table 2 , it can be seen that all cofactor requirements for the first five pathway steps are fulfilled. However, steps 6 and 7 require ferredoxin or flavodoxin and Rohdich et al. (1999) G7423 Lüttgen et al. (2000) ; Lange and Croteau (1999) ferredoxin (flavodoxin) NADP + reductase to couple the reaction to NADPH for electron transfer. Furthermore, both ispG and ispH are iron-sulfur cluster proteins which need to be loaded with a [4Fe-4S]-iron-sulfur cluster (ISC) to be functional (Seemann and Rohmer 2007) . Ferredoxin is also an [2Fe-2S] ISC protein (Blaschkowski et al. 1982) .
ISC proteins are ubiquitously found throughout nature, but the approach of assembling these varies from species to species. Three different ISC assembly pathways have so far been discovered in bacteria, namely, the nitrogen fixation, ISC, and sulfur mobilization pathway (Tokumoto et al. 2004) , whereas a conserved ISC assembly machinery located in the mitochondria is present in eukaryotes. This machinery has been inherited from a bacterial ancestor of the mitochondria and therefore has high similarity to the ISC assembly machinery found in bacteria (Mühlenhoff and Lill 2000) . However, despite localization in the mitochondria, the eukaryotic ISC assembly machinery must supply ISCs to apoproteins throughout the cell. This is carried out by the cytosolic ironsulfur cluster assembly machinery (CIA; Lill and Mühlenhoff 2008) . The CIA machinery is not well characterized, and the exact mechanisms responsible for targeting cytosolic and nuclear apoproteins to be loaded with ISCs exported from the mitochondria are unknown. This obviously complicates engineering of ispG and ispH to functionalize the gene products within the cytosol of S. cerevisiae; in order to remedy this situation, we decided to co-express the E. coli ISC assembly machinery with the heterologous MEP pathway.
The core functions in ISC biogenesis in E. coli are encoded by a single gene cluster composed of the following genes: iscR-transcriptional regulator, iscS-cysteine desulferase (sulfur donor), iscU-scaffold, iscA-A-type protein, hscA-DnaJ-like co-chaperone, hscB-DnaK-like chaperone, fdx-ferredoxin, and iscX-unknown function, found to interact with iscS (Py and Barras 2010; Tokumoto et al. 2002) . In addition to these eight genes, the ErpA gene, encoding another A-type protein, is essential in E. coli for converting ispG from its apo form to its holo form (Loiseau et al. 2007 ). Furthermore, the E. coli CyaY gene, encoding frataxin, takes part in ISC assembly, probably as an iron donor (Yoon and Cowan 2003) . Bedekoviks et al. (2007) showed that a mitochondrially targeted version of the E. coli CyaY gene could functionally complement the yfh1 deletion in S. cerevisiae (Bedekovics et al. 2007 ). Yfh1 has previously been found to be important for ISC biogenesis in yeast, hereby further strengthening the evidence that frataxin is required for ISC assembly (Duby et al. 2002) . Finally, Justino et al. (2007) showed that the E. coli YtfE-encoded protein acts as a repair protein to mend ISC proteins that have been damaged due to nitrosative stress (Justino et al. 2007) .
Iron storage and sequestration in a biological system is of outmost importance to ensure that the iron is soluble and thereby accessible where necessitated and to avoid the formation of reactive oxygen species, e.g., through the HaberWeiss-Fenton reaction, which generates hydroxyl radicals (Aisen et al. 2001) . Most organisms use the polymeric protein ferritin to store iron. Even though S. cerevisiae contains ferritin, the majority of the iron stored within the cell is located in the vacuole (Raguzzi et al. 1988) . Little is known about how iron is transported within the yeast cell, and it is unknown whether the iron stored in the vacuole is available to a heterologous ISC machinery. It has previously been found that iron storage in S. cerevisiae, and therefore tolerance toward stress induced by high extracellular iron concentrations, can be improved by heterologous expression of human heteropolymeric ferritin (Kim et al. 2003) . We therefore decided to additionally express the E. coli Bfr, FtnA, and Bfd genes, encoding the bacterioferritin, ferritin, and bacterioferritin-associated ferredoxin, respectively. These iron storage genes together with the ISC machinery genes, the ISC repair gene, and the Fdx, Fpr, and FldA genes, encoding ferredoxin, ferredoxin (flavodoxin) NADP + reductase, and flavodoxin 1 (Bianchi et al. 1993; Nakamura et al. 1999; Puan et al. 2005) , make up the supporting system that we hypothesized would be required to functionalize the MEP pathway expressed in S. cerevisiae. Here, we report the cloning and expression of these 16 genes combined with the eight MEP pathway genes (including Idi), together with a quantitative analysis of this complex system.
Materials and methods

Chemicals, enzymes, and growth media
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich® (St. Louis, MO) and all enzymes from New England Biolabs Inc. (Ipswich, MA). E. coli cells were grown in BD Difco TM LB broth from BD Diagnostic Systems (Sparks, MD). For selection and maintenance of plasmids, ampicillin was added to a final concentration of 100 mg/L. S. cerevisiae cultures that required no auxotrophic selection were grown on YPD, composed of 10 g/L Bacto™yeast extract (BD Diagnostic Systems), 20 g/L Bacto™ peptone (BD Diagnostic Systems), and 20 g/L dextrose. For auxotrophic selection, S. cerevisiae was grown on SC medium with the appropriate nutrient(s) omitted or SD for prototrophic strains. The SC medium was composed of 6.7 g/L yeast nitrogen base (YNB) without amino acids (BD Diagnostic Systems), CSM amino acid dropout mixture (amount according to the manufacturer's recommendation; Sunrise Science Products, Inc., San Diego, CA), and 20 g/L dextrose or galactose. SD was made the same way as SC, with the difference of omitting the CSM amino acid dropout mixture. All media components and media besides YNB were sterilized by autoclaving. YNB was sterilized by filtration.
Plasmids and strains
The strains and plasmids acquired for this study can be seen from Table 2 . Every cloning for the construction of the plasmids described below was carried out by treating the recipient plasmids with endonuclease(s), purification by gel electrophoresis, and recovery by gel extraction using the PureLink™ Quick Gel Extraction Kit (Life Technologies, Grand Island, NY), followed by ligation to the insert using T4 DNA ligase. Each insert was either prepared by removing it from the plasmid harboring it by endonuclease digestion followed by gel electrophoresis and purification in the same way as the recipient plasmid or amplified by PCR, purified using the QIAquick PCR Purification Kit (Valencia, CA), treated with endonucleases and purified again using the QIAquick PCR Purification Kit. 
Construction of expression cassettes
For the expression of the genes of interest, four expression cassettes were created and tested for their ability to mediate transcription by verifying that they could express the yeastenhanced green fluorescent protein (yeGFP). This was done on the basis of the plasmids pRS414TEF and pRS415GPD in which the yeGFP from pKT127 was inserted by SpeI/XhoI digestion. The pRS414TEF with the insert yeGFP was modified by exchanging the CYC1t with the ADH1t, ACT1t, and ENO2t by XhoI/KpnI digestion. The TEF1p was substituted with the PGK1p in the plasmid with the ACT1t, and with the TEF2p in the plasmid with the ENO2t, by SacI/SpeI digestion. The replacement promoters and terminators were obtained by PCR from CEN.PK 113-7D genomic DNA (gDNA) using the primers containing adaptamers with the respective restriction sites (see Table 3 ). This resulted in the construction of four expression cassettes harboring yeGFP, namely, the TEF1p-yeGFP-ADH1t, TDH3p (GPDp)-yeGFP-CYC1t, PGK1p-yeGFP-ACT1t, and TEF2p-yeGFP-ENO2t in the pSCX001, pSCX002, pSCX003, and pSCX004 plasmids, respectively.
The eight MEP pathway genes were purchased codonoptimized for S. cerevisiae from DNA 2.0 (Menlo Park, CA), flanked by SpeI (5′) and XhoI (3′) restriction sites. The sequences of the codon-optimized genes have been deposited to Genbank, cf. idi (accession no. KC571266), ispH (accession no. KC571267), dxr (accession no. KC571268), ispG (accession no. KC571269), dxs (accession no. KC571270), ispE (accession no. KC571271), ispD (accession no. KC571272), and ispF (accession no. KC571273). Using these restriction sites, the genes were cloned into expression cassettes (see Table 4 ). The 16 ISC assembly machinery genes were amplified from E. coli K12, MG1655 gDNA using Phusion® High-Fidelity DNA Polymerase (applied for all PCR reactions described in "Materials and methods") and primers listed in Table 4 . The forward and reverse primers were designed with adaptamers containing the SpeI and XhoI restriction sites, respectively. These restriction sites were used to clone the genes into their designated expression cassettes. Electronic supplementary material (ESM) Fig. S1 shows the graphical overview of the expression cassette construction.
Construction of plasmids for integration of multiple expression cassettes
To integrate the eight MEP pathway genes in the genome of S. cerevisiae, two plasmids with four expression cassettes each were constructed based on the pUC19 plasmid. A 1,750-bp fragment containing the HIS2 open reading frame (ORF) with 352 bp upstream of the start codon and 390 bp downstream of the stop codon and a 1,427-bp fragment containing the ADE1 ORF with 332 bp upstream of the start codon and 274 bp downstream of the stop codon were amplified from CEN.PK113-7D-derived gDNA by PCR with primers containing HindIII adaptamers (see Table 3 ) and separately cloned into pUC19 digested with HindIII. The direction of the insert was determined by sequencing. The AatII sites in the backbone of the constructed vectors and in the HIS2 ORF were removed by introducing silent point mutations using the QuikChange® Multi Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). A new multiple cloning site comprising two complementary primers (5′-GCGCGAGCTCCTC-
which were annealed and subsequently digested with SacI and KpnI, were inserted into the plasmids treated with SacI and KpnI to create pSC600 (with the HIS2 marker) and pSC700 (with the ADE1 marker).
dxs, ispF, ispE, and ispD were treated with SpeI and XhoI restriction endonucleases and inserted into pSCX001, pSCX003, pSCX002, and pRS414TEF, respectively, hereby creating the following expression cassettes: TEF1p-dxsADH1t, PGK1p-ispF-ACT1t, TDH3p-ispE-CYC1t, and TEF1p-ispD-CYC1t. ispG, ispH, ispC, and idi were treated with SpeI and XhoI restriction endonucleases and inserted into pRS414TEF, pSCX002, pSCX003, and pSCX001, respectively, hereby creating the following expression cassettes: TEF1p-ispG-CYC1t, TDH3p-ispH-CYC1t, PGK1p-ispC-ACT1t, and TEF1p-idi-ADH1t. The cassettes were amplified by PCR with the primers listed in Table 3 , purified, and digested with the sets of restriction endonucleases also stated in Table 3 . The dxs, ispF, ispE, and ispD expression cassettes were in the order listed here sequentially inserted in pSC600 to create pSC604. The ispG, ispH, ispC, and idi expression cassettes were in the order listed here sequentially inserted in pSC700 to create pSC704. For chromosomal integration of the expression cassettes containing the bfr, FtnA, bfd, and YftE genes, a plasmid based on the pUC19-derived pSC700 plasmid was applied. The genes were amplified from E. coli K-12, MG1655 gDNA by PCR with primers listed in Table 4 , digested with SpeI and XhoI, and purified. YtfE and FtnA were inserted into the pSCX002 plasmid treated with SpeI and XhoI by ligation, and bfr and bfd in the same way into pSCX001 and pSCX002, respectively. The following expression cassettes were hereby constructed: TDH3p-YtfE-CYC1t, TEF1p-bfr-ADH1t, PGK1p-bfd-ACT1t, and TDH3p-FtnA-CYC1t. The expression cassettes were amplified by PCR using the primers listed in Table 3 and digested with the sets of restriction endonucleases specified in Table 3 . The YtfE, bfr, bfd, and FtnA expression cassettes were in the order listed here sequentially inserted into pSC700, whereafter the ARG4 marker was inserted between the HindIII and BamHI sites to construct pSC804. The ARG4 marker was prior to the insertion amplified from CEN.PK113-7D-derived gDNA with primers designed to amplify a DNA sequence from 546 bp upstream of the start codon to 364 bp downstream of the stop codon (primers listed in Table 3 ), digested with HindIII and BamHI, and purified.
To ensure high expression of the 12 remaining ISC assembly machinery genes, we created two plasmids with six of the expression cassettes each, targeting them into the YPRCδ15 and YPRCτ3 loci, respectively, since the integration of two different lacZ expression cassettes into these Ty remnants has given high expression (Flagfeldt et al. 2009 ). We first separately introduced DNA sequences homologous to the upstream parts of the YPRCδ15 and YPRCτ3 loci into pUC19. The DNA was amplified from F1702-derived gDNA using reverse primers containing adaptamers which introduced the AvrII and NotI restriction sites. These two sites were used to digest the two plasmids, and the first two expression cassettes were amplified with primers introducing a NheI restriction site in front of the promoter and an AvrII and a NotI restriction site following the terminator; since AvrII and NheI are compatible, this allowed the insert treated with NheI and NotI to be inserted into the two plasmids, leaving behind a new set of AvrII and NotI restriction sites. This approach was iteratively used (see ESM Fig. S2 ) to insert the expression cassettes into the two plasmids, finally creating the plasmid pSCFeS107TRP, containing the iscX, iscR, iscS, fdx, TRP1, cyaY, and iscU expression cassettes, and pSCFeS207LEU, containing hscB, fpr, iscA, erpA, LEU2, hscA, and fldA. The last insert in each of the two plasmids was the DNA sequences homologous to the downstream of the YPRCδ15 and YPRCτ3 loci, respectively. All primers used for the construction of pSCFeS107TRP and pSCFeS207LEU are listed in Table 3 . A schematic representation of the construction of the plasmids for the integration of multiple expression cassettes is summarized in ESM Table S1 . 
Construction of other plasmids
ERG13 was deleted by a cassette constructed by introducing a 213-bp sequence identical to the gDNA sequence upstream of the ERG13 start codon between the HindIII and PstI restriction sites and a 272-bp sequence identical to the gDNA sequence downstream of the ERG13 stop codon between the SpeI and SacI restriction sites of pUG72, hereby creating plasmid pSCΔ001. The sequences were amplified from F1702-derived gDNA using the primers listed in Table 3 . To test whether leuC and leuD can complement the leu1 auxotrophy, three plasmids were constructed, namely, pESCleuC, pESC-leuC/D, and pESC-LEU1. pESC-leuC was constructed from pESC-URA by inserting leuC between the BamHI and HindIII restriction sites. pESC-leuC-D was constructed by inserting leuD between the EcoRI and SacI sites of pESC-leuC. a Primer direction defined according to the direction of translation of the ORF b These genes were purchased codon-optimized with flanking restriction sites and sub-cloned, so no primers were required to clone these genes into their individual expression cassettes. The primers listed here are therefore the primers used for verification of genomic inserts and RT-PCR Underlined entries are the nucleotides corresponding to the restriction enzymes
The pESC-LEU1 plasmid was constructed by inserting LEU1 between the BamHI and XhoI restriction sites of pESC-URA. LeuC and leuD were amplified from E. coli gDNA and LEU1 from F1702 gDNA using the primers listed in Table 3 . All final plasmids constructed in this study are listed in Table 5 , and their maps can be seen from ESM Fig. S3 .
Construction of yeast strains
All transformations of S. cerevisiae were carried out using the lithium acetate/polyethylene glycol method according to Daniel Gietz and Woods (2002) . Transformants were selected on SC with the appropriate nutrient(s) omitted. The constructed strains were verified by extraction of gDNA using the Wizard® Genomic DNA Purification Kit (Promega, Madison, WI), followed by PCR amplification of all the integrated ORFs. Selfreplicating plasmids were used directly to transform S. cerevisiae, whereas the plasmid destined for genomic integration was linearized. Prior to the transformation of S. cerevisiae, the plasmids pSC604, pSC704, and pSC804 were linearized by digestion with MscI, HpaI, and AgeI endonucleases, respectively, to facilitate their integration into the non-functional markers present in the yeast genome. The pSCFeS107TRP and pSCFe-S207LEU integration cassettes were removed from their respective plasmids by digestion with PacI and NotI endonucleases, and the ERG13 deletion cassette was removed from the pSCΔ001 plasmid by NotI and SacII digestion. The order in which the strains were constructed by transformation with the individual plasmids or cassettes can be seen from Table 6 .
Test of expression cassette functionality using yeGFP
The strains SCX001, SCX002, and SCX004 were grown on SC-TRP and SCX003 on SC-LEU plates at 30°C until colonies had formed. To test the expression of yeGFP, the colonies were visually inspected using the Safe Imager™ 2.0 Blue-Light Transilluminator (Life Technologies), with corresponding filter.
Liquid chromatography-mass spectrometry analysis of the MEP pathway metabolites SCMEP and SCMEP-FeS2-IS were grown in 5 mL SC-ADE-HIS and SC-ADE-ARG-HIS-LEU-TRP, respectively, at 30°C at 250 rpm orbital shaking until the OD 600 reached 1. Cell suspensions equivalent to 3 mL OD 600 =1 cells were withdrawn at the middle exponential growth phase for measuring MEP pathway metabolites. Cell suspension was centrifuged for 1 min and the cell pellets resuspended in 1 mL acidic extraction solution (40:40:20 methanol/acetonitrile/ddH 2 O, 0.1 M formic acid). The cells were completely lysed using 200-μL glass beads in Mini-Beadbeater-16 (Biospec). Following centrifugation, the supernatant was purified through a LC-NH2 resin (Sigma). The resin bound with the metabolites was eluted with 400 μL 1 % NH 4 OH solution after centrifugation, and the pH of the eluate was subsequently adjusted to acidic (pH 5) by 3 μL acetic acid (Zhou et al. 2012b ). An aqueous solution containing 15 mM acetic acid and 10 mM tributylamine, and methanol were used as the mobile phase with a UPLC C18 column (1.7 μm, 2.1×50 mm; Waters CSH C18) as follows. The elution was done at 0.15 mL/min with gradient (start, 0 % methanol; 1.8 min, 0 % methanol; 3.1 min, 40 % methanol; 4.9 min, 40 % methanol; 5.4 min, 90 % methanol; 9.5 min, 90 % methanol; 10 min, 0 % methanol). Electrospray ionization was used and mass spectrometry was operated to scan 50-800m/z in negative mode with −500-V end plate voltage and 4,500-V capillary voltage. Nebulizer gas was provided in 1 bar, the drying gas rate was 9 mL/min, and dry gas temperature was 200°C. Sample injection volume was 5 μL. Retention times are 5.6 and 6.6 min for DXP (m/z=213.0170) and MEC (m/z=276.9884), respectively. The peak area was integrated for each metabolite with the software provided by the manufacturer.
Analysis of pathway functionality using U-13 C 6 glucose Strain SCMEP-FeS2-IS-ΔERG13 was inoculated at OD 600 = 0.05 in 5 mL SD medium made with U-13 C 6 glucose (Cambridge Isotope Laboratories, Andover, MA) and grown aerobically for 2 days at 30°C with 250-rpm orbital shaking. The cells were spun down at 3,000 rpm for 10 min, resuspended in 2 mL 20 % (w/v) sodium hydroxide in 50 % ethanol, transferred to an 8-mL glass tube, and extracted according to Madsen et al. (2011) . The extract was dried, redissolved in 50 μL pyridine, derivatized by the addition of 50 μL N,Obis(trimethylsilyl)trifluoroacetamide (BSTFA)+1 % trimethylchlorosilane according to Nielsen and Madsen (2000) , and analyzed using GC-MS. A 1-μL sample was analyzed using splitless injection on a DB 35-ms, 30-m, 0.25-mm, 0.25-μm column (Agilent Technologies, Santa Clara, CA) with helium as the carrier gas. The temperature of the oven was initially held at 160°C for 30 s, then increased to 320°C at 10°C/min, and finally held at 320°C for 3 min. Ergosterol and squalene standards were subjected to the same procedure for authentication.
Verification of gene expression by RT-PCR
S. cerevisiae cultures (5 mL) were grown at 30°C until OD 600 =1, whereafter the cells were harvested by centrifugation at 3,000×g for 10 min and washed with TE buffer. They were transferred to a 2-mL FastPrep® tube (MP Biomedicals LLC, Solon, OH) and resuspended in 500 μL TE buffer. Two hundred-microliter acid-washed glass beads (425-600 μm, Sigma-Aldrich®) and 500 μL acidic phenol-chloroform-isoamyl alcohol (125:24:1), pH 4.5 (Life Technologies) were added. The cells were disrupted using a Savant FastPrep® FP120 Cell Disrupter (MP Biomedicals LLC). The phases were separated by centrifugation at 18,000×g for 10 min, and 450 mL of the aqueous phase was transferred to a microcentrifuge tube. Total RNA was precipitated by the addition of 3 M sodium acetate (45 μL, pH 5.2) and isopropanol (450 μL), rinsed twice with 80 % ethanol (500 μL), and redissolved in nuclease-free water (90 μL; Qiagen, Valencia, CA). The RNA was treated with DNase I, extracted with acidic phenol-chloroform-isoamyl alcohol (125:24:1, 400 μL, pH 4.5) and TE buffer (pH 8.0, 400 μL), then precipitated by sodium acetate and isopropanol and finally redissolved in nuclease-free water (100 μL). This RNA served as the template for RT-PCR using the Illustra™, Ready-ToGo™, RT-PCR Beads from GE Healthcare Biosciences (Pittsburgh, PA). The RNA solution was checked for DNA contamination by PCR using the Taq DNA polymerase. The PCR products were visualized by gel electrophoresis (0.75 % agarose in TAE) and staining by Sybr® Safe (Life Technologies).
Evolution of S. cerevisiae by serial sub-culturing
Strain SCMEP-FeS2-IS-ΔERG13 was inoculated from glycerol stock in SC-ADE-ARG-HIS-LEU-TRP-URA medium (5 mL) supplemented with mevalonolactone (10 g/L). The strain was incubated at 30°C for 5 days with 250-rpm orbital shaking. Hereafter, the OD 600 was measured and reinoculated into SC-ADE-ARG-HIS-LEU-TRP-URA (5 mL) with mevalonolactone (5 g/L) at OD 600 =0.1. This periodical re-inoculation was continued, reducing the mevalonolactone concentration with every re-inoculation. Mevalonolactone was prepared as a stock solution (500 g/L) according to Dimster-Denk et al. (1994) by dissolving it in dH 2 O at 65°C for 1 h followed by filter sterilization.
Microscopy
The morphology of cells from the serial sub-culturing was investigated using a Nikon Eclipse TE200-S microscope (Nikon Instruments Inc., Melville, NY). The bright-field images were obtained at ×1,000 magnification.
Functional complementation of leu1 auxotrophy
Strains SC-pESC, SC-leuC, SC-leuC-D, and SC-LEU1 were streaked out on SC (galactose)-LEU-URA plates from glycerol stock and incubated at 30°C for 4 days; growth was assessed and documented by photography of the plates.
Results
In order to develop a compatible expression system for multiple genes expression, initially, we constructed four plasmids based on the pRS series of S. cerevisiae/E. coli shuttle plasmids (Mumberg et al. 1995) . Each plasmid containing an expression cassette harboring the gene encoding yeGFP was transformed into S. cerevisiae F1702, and their ability to mediate expression was verified by visual inspection of the resulting colonies (data not shown). The four expression cassettes then served as starting points for creating 24 individual expression cassettes harboring the genes listed in Table 4 . After systematic assembly of the 24 expression cassettes into five plasmids designed for chromosomal integration, the plasmids were one by one integrated into the genome of F1702. The first two plasmids to be integrated were pSC604 and pSC704, harboring the codon-optimized genes encoding the MEP pathway enzymes to construct the strain designated SCMEP. gDNA from SCMEP was isolated and used as the template for PCR reactions, confirming that all the genes were indeed integrated (results not shown). To test whether the heterologous MEP pathway could supply the IPP required to sustain growth, we tried to delete the ERG13 gene using a deletion cassette. We were unable to obtain viable colonies from which the ERG13 gene had been knocked out. Several false positive colonies were obtained, probably due to integration of the deletion cassette at a nonspecific locus. The SCMEP strain was then subjected to analysis using UPLC-MS, by which we detected 3.2±0.29 mg DXP per gram dry cell weight (DCW) and 5.0±1.8 mg MEC per gram DCW (the value following ± is the standard error of the mean). These results prove that the MEP pathway is active until MEC, but whether the last two steps are active is impossible to determine based on these results since no Fig. 2 Verification of genomic integrated genes in SCMEP-FeS2-IS strain and deletion of ERG13. a To verify that all the genes had been inserted into the genome of SCMEP-FeS2-IS, gDNA was purified and used as the template for the amplification of the individual ORFs using the primer pairs listed in Table 4 . The amplification product was visualized by gel electrophoresis on 0.75 % agarose gel in TAE buffer. Numbering of lanes corresponds to the following ORFs: 1, iscX (0.20 kb); 2, iscR (0.49 kb); 3, iscS (1.22 kb); 4, fdx (0.34 kb); 5, CyaY (0.32 kb); 6, iscU (0.39 kb); 7, hscB (0.52 kb); 8, fpr (0.75 kb); 9, iscA (0.32 kb); 10, erpA (0.35 kb); 11, hscA (1.85 kb); 12, fldA (0.53 kb); 13, bfr (0.48 kb); 14, FtnA (0.50 kb); 15, bfd (0.20 kb); 16, YtfE (0.66 kb); 17, dxs (1.86 kb); 18, ispE (0.85 kb); 19, ispF (0.48 kb); 20, ispD (0.71 kb); 21, idi 2 (0.55 kb); 22, ispH (0.95 kb); 23, dxr (1.19 kb); 24, ispG (1.12 kb). b gDNA purified from the following strains: 1, SCMEP-FeS2-IS-ΔERG13-colony13; 2, SCMEP-FeS2-IS-ΔERG13-colony25; 3, SCMEP-FeS2-IS-ΔERG13-colony29; 4, F1702 was used as templates for PCR reactions using the primers shown in Table 3 . The PCR reactions of the ERG13UP (1.00 kb) and ERG13DOWN (0.90 kb) fragments verify that the deletion cassette has been inserted in the correct locus, and the inability to amplify the ERG13ORF (1.47 kb) from templates 1, 2, and 3 verifies that ERG13 has not been duplicated prior to the knockout HMBPP (detection limit=0.2 mg/L) could be detected, and it is impossible to discriminate between the IPP originating from the MVA and MEP pathways. This indicated that the MEP pathway is insufficient at supplying precursors in quantities that can support growth. However, this is the first time that DXP and MEC have been produced and detected in a S. cerevisiae strain.
The last two steps of the MEP pathway are catalyzed by ISC proteins, which require an elaborate support machinery to load the apoproteins with ISC and couple these to NAD(P)H cofactor metabolism for supplying reducing equivalents. To alleviate this potential problem, we delineated the proteins that we, based on the literature, hypothesized could be sufficient to decouple the ISC assembly system from E. coli and graft it into the cytosol of S. cerevisiae. The 16 genes encoding these proteins were by the plasmids pSCFeS107TRP, pSCFeS207LEU, and pSC804 integrated into the genome of SCMEP to construct SCMEP-FeS2-IS. gDNA was isolated from SCMEP-FeS2-IS, and all 24 genes were verified by PCR to be inserted within its genome. The results of the PCR can be seen from Fig. 2a .
After verifying that all the genes had been inserted into the chromosome, we once more tried to delete the ERG13 gene, but no viable colonies were obtained. This result does, as aforementioned, not prove that the MEP pathway is inactive but only that the activity is too low to support growth, so we once again tested the strain using LC-MS, but have not observed any significant change in MEC compared to the SCMEP strain. However, the DXP concentration had increased to 7.9±1.4 mg/g DCW; currently, the reason for increased accumulation of DXP is unknown. To be able to delete ERG13, we had to supplement the medium with 10 g/L mevalonolactone, which serves as a source for mevalonate. Thirty colonies were screened by extraction of gDNA followed by PCR. Three colonies (colonies 13, 25, and 29) were identified by PCR to have the deletion cassette integrated in the correct locus and no duplication of ERG13 prior to the deletion (Fig. 2b) . These strains were named SCMEP-FeS-IS-ΔERG13-strain13, SCMEP-FeS-IS-ΔERG13-strain25, and SCMEP-FeS-IS-ΔERG13-strain29.
In order to find out whether the MEP pathway is active in the SCMEP-FeS2-IS-ΔERG13 strains isolated, they were grown on SD medium made with uniformly 13 C-labeled glucose and unlabeled mevalonolactone as carbon sources. Since ERG13 was deleted, the only way labeled carbon can end up in IPP is if the MEP pathway is active. IPP is the first isoprenoid precursor of ergosterol, which is made from 2 FPP units (equivalent to 6 IPP units) forming squalene, which then undergoes several modifications to form ergosterol. During these modifications, three carbon atoms are lost due to the C14-demethylase and C4-decarboxylase activities encoded by ERG11 and ERG26, respectively. Furthermore, a carbon is gained through the activity of the C24-methyl transferase, encoded by ERG6 (Veen and Lang 2004) . If the MEP pathway is active, one would expect to see a shift in the molecular weight of ergosterol of 3 Da or higher, whereas a shift of 1 Da just indicates the labeled carbon gained from the C-24 methyl transferase. The ergosterol extracts from the three strains grown on the medium with either uniformly 13 C-labeled glucose or regular glucose were analyzed on GC-MS and the peaks corresponding to squalene and ergosterol identified by comparisons of squalene and ergosterol standards. An example of the results obtained from this analysis can be seen from ESM Fig. S4 . The peak for the molecular weight of the unfragmented ergosterol derivatized with BSTFA is located at approximately 468 Da (corresponding to the M0 peak), and its eight mass isotopomers peaks-M1, M2, M3, M4, M5, Fig. 3 Ergosterol mass isotopomer distribution. Integration of the peak areas of the ergosterol 468 Da (corresponding to M0) and 27 of its mass isotopomers (only the first eight are shown since the area of every mass isotopomer peak above 5 is close to 0) at increments of 1 Da normalized to the total abundance. The labeled results are from ergosterol extracted from SCMEP-FeS-IS-ΔERG13 grown on U-13 C6 glucose, whereas the unlabeled results are from SCMEPFeS-IS-ΔERG13 grown on regular glucose. The experiment was done in biological triplicates M6, M7, and M8 (corresponding to M0+increments of 1 Da, respectively)-were integrated for ergosterol isolated from the SCMEP-FeS2-IS-ΔERG13 strain grown on either uniformly C 13 -labeled glucose or regular glucose in triplicate. The results from all the strains were almost identical. The result from SCMEP-FeS-IS-ΔERG13-strain13 can be seen from Fig. 3 . The species that are heavier than M0 and M1 for the unlabeled and labeled, respectively, are due to the natural occurrence of C
13
. These results show a shift of 1 Da from the unlabeled to the labeled, which indicates that the MEP pathway has a very limited flux, if any at all.
To test whether all 24 genes were expressed, total RNA was isolated from SCMEP-FeS2-IS and tested for residual DNA by PCR. No DNA was found (results not shown). The RNA was used as the template in RT-PCR reactions with primer pairs (Table 4) designed to amplify the entire ORF of the individual genes. The result of the RT-PCR reactions (Fig. 4) showed that, except for bfd, fldA, and hscA, all the genes are expressed. The experiment was therefore repeated, and bfd and fldA were also shown to be expressed (data not shown). However, it was not possible to detect any band for hscA. Since the same four promoters were used to express the genes, and as all other genes expressed by the same promoter as hscA were expressed, the failure to detect transcription could be due to low mRNA stability, either in vivo or post-cell breakage. However, lack of hscA expression is presumably not detrimental for the functionality of the ISC assembly machinery since it has been found in vitro to be stimulatory rather than absolutely required for the transfer of ISC from the assembly machinery to the apoproteins (Mansy et al. 2002) .
To investigate the possibility that the SCMEP-FeS2-IS-ΔERG13 strains have a finite, albeit low, flux through the MEP pathway that could be increased, we set out to adapt the cultures to grow with IPP being solely supplied by the MEP pathway by serial sub-culturing with decreasing amounts of mevalonolactone. Adaptive evolution has previously been found efficient for the growth of engineered S. cerevisiae strains on xylose (Zhou et al. 2012a ). The result of the evolution is summarized in Fig. 5 . The newly created SCMEP-FeS2-IS-ΔERG13 strains needed 5 g/L mevalonolactone to grow (results not shown), which corresponds with the value reported by Umebayashi and Nakano (2003) . However, serial sub-culturing for more than a half year resulted in two of the strains being able to grow to a similar OD 600 in medium with 5 mg/L mevalonolactone, i.e., 1,000-fold less. Despite this strong adaptation, no mevalonateindependent cells could be isolated. In other words, the heterologous MEP pathway was still unable to support growth. This suggests that the MEP pathway is inactive since one would expect it to be possible to evolve a pathway directly linked to growth with low activity to higher activity, whereas evolving a pathway with no activity to become active is less likely. During the directed evolution, the morphology of the cells was observed using light microscopy. Figure 6 shows the morphology of the three SCMEP-FeS2-IS-ΔERG13 strains grown in SC-ADE-ARG-HIS-LEU-TRP-URA+0.25 g/L mevalonolactone. It can be seen that strains 25 and 29 exhibit abnormal morphology, probably due to the stress of low mevalonate availability.
In order to test whether S. cerevisiae can functionally express other heterologous [4Fe-4S] ISC proteins from E. coli within its cytosol, we decided to test whether the S. cerevisiae strain JAY20, auxotrophic for leucine due to a deletion of the LEU1 gene, encoding the second step in the biosynthesis of leucine, catalyzed by the isopropylmalate isomerase could be complemented by the E. coli heterodimeric isopropylmalate isomerase, encoded by leuC and leuD (Skala et al. 1991) . The leuC gene was inserted in the pESC-URA plasmid followed by leuD, hereby constructing plasmids pESC-leuC and pESCleuC-D, respectively. As a positive control, LEU1 from F1702 was inserted in pESC-URA as well. These three plasmids, together with the pESC-URA plasmid, which served as the negative control, were used to transform JAY20. Expression of the genes integrated in pESC-URA was under control of the GAL1/GAL10 inducible promoter system. The four strains were plated on SC-LEU-URA with galactose as the carbon source. The result can be seen from Fig. 7 and shows that pESC-leuC-D can complement the LEU1 auxotrophy. leuC and leuD do, however, have a high degree of homology with LEU1, which could explain why they can be loaded with ISC. The mechanism of targeting apo-ISC proteins to be loaded with ISC and hereby converted to their active holo form has not yet been elucidated, but this result demonstrates that bacterial ISC proteins heterologously expressed in S. cerevisiae can be converted to their functional holo form.
The finding that S. cerevisiae is capable of loading cytosolic heterodimeric isopropylmalate isomerase encoded by leuC and leuD with ISCs does not imply that all bacterial ISC proteins heterologously expressed within the yeast cytosol can be loaded with ISCs. ispG and ispH are not the only two ISC proteins among the proteins required for MEP Fig. 6 Microscope pictures of evolved SCMEP-FeS-IS-ΔERG13 strains. The strains were grown in SC-ADE-ARG-HIS-LEU-TRP-URA+0.25 g/L mevalonolactone for 5 days before the morphology was assessed by light microscopy. a SCMEP-FeS-IS-ΔERG13-strain13. b SCMEP-FeS-IS-ΔERG13-strain25. c SCMEP-FeS-IS-ΔERG13-strain29 Fig. 7 Complementation of the leu1 auxotrophy in the JAY20 S. cerevisiae strain. JAY20 transformed with pESC-URA, pESC-leuC-D, pESC-LEU1, and pESC-leuC was plated on SC-LEU-URA and incubated at 30°C for 3 days functionality. Ferredoxin is also an [2Fe-2S] ISC protein (Ta and Vickery 1992) , and it is involved in the transfer of electrons to ispG and ispH, as well as electron transfer to ISC biogenesis. To be functional, ferredoxin therefore needs to be loaded with an ISC, which has to originate from the yeast CIA machinery since it cannot originate from the heterologous ISC assembly machinery; this is because no ISC can be generated through the heterologously expressed ISC assembly machinery before ferredoxin is converted to its active holo form. With ferredoxin as a pivotal point for MEP pathway functionality, emphasis on research to assess whether this protein can be converted to its holo form is required. If ferredoxin is found only in its apo form, research should focus on adapting it to be loaded with ISC via the CIA machinery since this will be key to functionally express the MEP pathway in the cytosol of S. cerevisiae.
Discussion
S. cerevisiae have several advantageous characteristics, making it an ideal host for the microbial production of isoprenoids such as well-established large-scale fermentation, enabling easy scale-up, GRAS classification by the FDA, which eases the approval of novel products, and compartmentalization for co-localization of enzymes; strains pre-engineered to express cytochrome P450 species that are important for the downstream decoration of the isoprenoid backbones have been demonstrated (Huang et al. 2008; Truan et al. 1993 ). The combination of S. cerevisiae with the stoichiometrical superior MEP pathway holds great potential for bypassing native regulation, hereby constructing an excellent platform for isoprenoid production. Our results-the MEP pathway is active until MEC and ISC proteins can be expressed in the cytosol of yeast-are encouraging for the further quest of functionalizing the MEP pathway in its entirety (Partow et al. 2012) .
The requirements for an elaborate ISC assembly machinery for ispG and ispH function, combined with the finding that MEC can be detected in a cell extract, suggest that the MEP pathway is only active until MEC. This is further supported by the lack of labeled carbon ending up in ergosterol through the MEP pathway, as well as the mevalonolactone requirement of the erg13Δ strains. This view contradicts the view expressed by Maury et al. (2008) , who used lovastatin in an attempt to find out whether the MEP pathway was active. However, the growth in the presence of lovastatin could have been caused by other circumstances, e.g., a mutation conferring resistance toward the drug. To circumvent the use of lovastatin, Maury et al. (2008) furthermore suggested deleting a gene encoding one of the early steps of the MVA pathway, such as ERG10, ERG13, or HMG1 and HMG2. We deleted ERG13 in strain SCMEP, which only expresses the MEP pathway genes, as well as in the SCMEP-FeS2-IS, expressing the MEP pathway together with all the support genes hypothesized to be required. In neither case were we able to obtain transformants that had lost ERG13 and could grow without mevalonolactone supplementation. Furthermore, previous research did not express any additional genes for coupling the ispG and ispH to NAD(P)H, such as ferredoxin, flavodoxin, and ferredoxin (flavodoxin) oxidoreductase (Maury et al. 2008) . S. cerevisiae natively possesses ferredoxin, but it is located within the mitochondria and found to be required for the assembly of ISC proteins (Lange et al. 2000) . No evidence of ferredoxin present in the cytosol of S. cerevisiae has been reported, and it is therefore probably not available for ispG and ispH. This is an additional reason to doubt that the MEP pathway was functional in the S. cerevisiae system presented by Maury et al. (2008) .
Further research into the requirements for targeting heterologous ISC apoproteins to be converted to their holo form through the CIA machinery could help functionalize the MEP pathway, whereas the approach of expressing the heterologous ISC machinery in S. cerevisiae could not only help functionalize the MEP pathway but also help us understand which parts of the E. coli ISC machinery are essential and how this system should be delineated. Alone from E. coli, 100 ISC proteins have been isolated (Fontecave 2006) , and being able to functionally express this group of ubiquitous proteins in S. cerevisiae encompasses great prospects for the biosynthetic production of novel compounds as well as obtaining a greater understanding of the complex processes involved in ISC assembly. A S. cerevisiae strain pre-engineered to express the machinery required for cytosolic expression of heterologous ISC proteins would therefore be a great tool in many areas within biotechnological and pharmaceutical research. Our work has showed the initial steps toward obtaining such strains and highlighted the obstacles on the way toward reaching this goal. This will hopefully spark further interest within the area of heterologous expression of ISC proteins.
